Fior Markets latest presentation named Global Nuclear Medicine Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024 centers around the progress of this market, focusing on its development status and trends.
Nuclear Medicine，or Radiopharmaceuticals， are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
DOWNLOAD FREE SAMPLE REPORT:https://www.fiormarkets.com/report-detail/365824/request-sample
Scope of the Report:
The global average price of Nuclear Medicine is in the decreasing trend, from 41.6 USD/Dose in 2011 to 39.5 USD/Dose in 2015. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of Nuclear Medicine includes Tc-99, I-123/131, In-111, Xe-133, Th-201 and Ga-67, and the proportion of Tc-99 in 2015 is about 51.60%, and the proportion is stable from 2011 to 2015.
Nuclear Medicine is widely used in Diagnostic, Therapeutic. The most proportion of Nuclear Medicine is Diagnostic, and the market share in 2015 is 61.23%. The trend of Diagnostic is decreasing.
The worldwide market for Nuclear Medicine is expected to grow at a CAGR of roughly 7.6% over the next five years, will reach 6610 million US$ in 2024, from 4590 million US$ in 2019.
This report focuses on the Nuclear Medicine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Global Nuclear Medicine market rivalry by leading manufacturers, together using production, cost, earnings (value) and market share for every producer; the best players as GE Healthcare, Bracco Imaging, Mallinckrodt, Lantheus Medical Imaging, Bayer, Triad Isotopes, Nordion, Jubilant Pharma, Eli Lilly, SIEMENS, China Isotope & Radiation, Dongcheng,
Further, the researchers have done the industry analysis to see the impact of numerous factors and understand the whole attractiveness of the industry. The market review helps to summaries the industrial and financial development within the industry through expert analysis. Later on, the report analyzes gross sales (volume & value), market share, market growth rate, market size on the basis of a variety of applications.
The report will also help organizations acquire new customers, discover high-value customers, and lessen the gap between churning and maintaining new clients. The market is assessed on the basis of revenue and volume as well as it includes the average revenue generated per user from the market. It serves all data with easily digestible information to help every businessman’s future innovation and move the business forward.
Key Questions Covered And Answered By The Report Include:
- Which end-user businesses will give continuous profitable results in the Nuclear Medicine market?
- Which are the fast developing regions in the market?
- Which tendencies and factors will impact industry economy development?
- Which are many product inventions helping manufacturers in promote to catch market share?
- What plans are organizations functioning in the global market holding to get a competitive advantage over their competitors?
Customization of the Report:This report can be customized to meet the client’s requirements. Please connect with our sales team (email@example.com), who will ensure that you get a report that suits your needs.